rheumatology
Allopurinol for Gout: How Long to Take It and What to Expect
Allopurinol reduces uric acid production to prevent gout flares by inhibiting the enzyme xanthine oxidase. Most people need three to six months before flares decrease noticeably. The 2020 ACR Gout Management Guideline recommends it as the preferred first-line urate-lowering medication, taken consistently for the long term.
Talk to a clinician
Nina Osei, NP — Nurse Practitioner
checkups, refills & skin. Gale can match you with a licensed clinician for a visit.
Find care →What is allopurinol and how does it work?
Allopurinol inhibits xanthine oxidase, the enzyme that produces uric acid in the body. By lowering the production of uric acid, allopurinol reduces the concentration of urate in the blood and tissues over time. When urate levels drop below the saturation point, existing uric acid crystals that have deposited in joints (the source of gout flares) slowly dissolve.
Gout is caused by monosodium urate crystal deposition in joints, which triggers a painful inflammatory response 2Ref 2Dalbeth N, Merriman TR, Stamp LK (2016).Gout.Pathophysiology of gout as monosodium urate crystal deposition; role of fructose and dietary factors in uric acid elevation. Allopurinol does not treat an active flare directly — it is a prevention strategy that works over months to years.
How long does allopurinol take to work?
This is one of the most common sources of frustration for people starting allopurinol:
- Uric acid levels begin to fall within weeks of starting allopurinol at an appropriate dose.
- Gout flares may temporarily increase in the first few months of treatment. This happens because lowering uric acid causes crystal deposits to become unstable and shed fragments, which trigger inflammation. This paradoxical increase in flares is well recognized and does not mean the medication is failing 1Ref 1FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. (2020).2020 American College of Rheumatology Guideline for the Management of Gout.Allopurinol as preferred first-line ULT; anti-inflammatory prophylaxis during initiation; HLA-B*5801 testing recommendation; indefinite ULT for recurrent gout; uric acid target of 6 mg/dL.
- Flare frequency typically decreases significantly after 6 to 12 months of consistent treatment, as crystal burden in the joints decreases.
- Tophi (large crystal deposits under the skin) may take years to fully dissolve.
To reduce early flares during the initiation period, the ACR guideline recommends concurrent anti-inflammatory prophylaxis — typically low-dose colchicine or a low-dose NSAID — for at least the first few months of urate-lowering therapy 1Ref 1FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. (2020).2020 American College of Rheumatology Guideline for the Management of Gout.Allopurinol as preferred first-line ULT; anti-inflammatory prophylaxis during initiation; HLA-B*5801 testing recommendation; indefinite ULT for recurrent gout; uric acid target of 6 mg/dL.
Do I have to take allopurinol forever?
For most people with recurrent gout, the answer from clinical guidelines is: yes, long-term and likely indefinite therapy is the goal.
The 2020 ACR Gout Management Guideline strongly recommends continuing urate-lowering therapy indefinitely for patients with recurrent gout (two or more flares per year), tophi, or gout-related joint damage 1Ref 1FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. (2020).2020 American College of Rheumatology Guideline for the Management of Gout.Allopurinol as preferred first-line ULT; anti-inflammatory prophylaxis during initiation; HLA-B*5801 testing recommendation; indefinite ULT for recurrent gout; uric acid target of 6 mg/dL. The rationale is straightforward: if urate levels rise again after stopping medication, crystal re-accumulation eventually resumes and flares return.
The target uric acid level on treatment is generally below 6 mg/dL (some guidelines use 5 mg/dL for those with tophi). Your clinician will monitor levels periodically with a blood test.
For someone who has had only one or two isolated flares without tophi, the decision about long-term medication may be more individualized — worth a frank conversation with your clinician about the balance of benefits and the burden of lifelong medication.
What are the side effects of allopurinol?
Allopurinol is generally well tolerated, but some important side effects to know about:
Common: - Increased gout flares during the first months of treatment (as described above) - Mild rash in a small proportion of people - Gastrointestinal upset (nausea, diarrhea)
Serious but uncommon: - Severe hypersensitivity reaction (allopurinol hypersensitivity syndrome, AHS). This rare but potentially serious condition involves rash (sometimes blistering), fever, and organ involvement. The risk is higher in people with kidney disease and in those who carry the HLA-B*58:01 genetic variant, which is more common in Southeast Asian, Korean, and Han Chinese populations. A prospective study in Taiwan found that screening for HLA-B*58:01 before prescribing allopurinol significantly reduced the incidence of severe cutaneous adverse reactions 3Ref 3National Institute of Arthritis and Musculoskeletal and Skin Diseases (2023).Gout: Symptoms, Causes, and Risk Factors.Gout as a type of inflammatory arthritis caused by urate crystal buildup; risk factors and disease stages including tophi formation. The ACR guideline recommends genetic testing before starting allopurinol in high-risk groups 1Ref 1FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. (2020).2020 American College of Rheumatology Guideline for the Management of Gout.Allopurinol as preferred first-line ULT; anti-inflammatory prophylaxis during initiation; HLA-B*5801 testing recommendation; indefinite ULT for recurrent gout; uric acid target of 6 mg/dL. - Kidney impairment. Allopurinol dose is adjusted based on kidney function, and monitoring is important.
Drug interactions: - Allopurinol interacts with azathioprine and 6-mercaptopurine (immunosuppressant drugs), substantially increasing their toxicity. This combination requires expert guidance. - Warfarin (blood thinner) levels may be affected.
Always tell your clinician about all medications and supplements you take before starting allopurinol.
What else helps alongside allopurinol?
Medication alone is most effective when paired with lifestyle changes that reduce uric acid:
- Limit alcohol, especially beer and spirits. Wine appears to have a smaller effect on uric acid than other alcohol types.
- Reduce purine-rich foods: organ meats (liver, kidneys), anchovies, shellfish, and red meat in large quantities raise uric acid.
- Stay well hydrated: adequate fluid intake helps the kidneys excrete uric acid.
- Achieve a healthy weight: excess body weight increases uric acid production.
- Limit sugary beverages and high-fructose corn syrup: fructose metabolism raises uric acid 2Ref 2Dalbeth N, Merriman TR, Stamp LK (2016).Gout.Pathophysiology of gout as monosodium urate crystal deposition; role of fructose and dietary factors in uric acid elevation.
Common questions
My gout flared right after I started allopurinol. Did it make things worse?
No — this is a recognized and expected phenomenon during the first months of urate-lowering therapy. As uric acid levels fall, crystal deposits shift and shed fragments that trigger inflammation. This does not mean you should stop allopurinol. Your clinician can prescribe a preventive anti-inflammatory (such as colchicine) to take alongside allopurinol during this period.
Is febuxostat an alternative if I cannot take allopurinol?
Yes, febuxostat is another xanthine oxidase inhibitor that works similarly to allopurinol and is an option for people who cannot tolerate allopurinol or who have a significant allergy. Your clinician can discuss the benefits and differences, including that febuxostat carries a specific FDA label about cardiovascular risk that your doctor will review with you.
Can I stop allopurinol once my uric acid is normal?
Stopping allopurinol will usually cause uric acid to rise again over weeks to months, eventually leading to crystal re-accumulation and recurrent flares. The current ACR guideline recommends indefinite treatment for people with recurrent gout or complications. Discuss any desire to stop with your clinician before doing so.
Talk to a clinician
Nina Osei, NP — Nurse Practitioner
checkups, refills & skin. Gale can match you with a licensed clinician for a visit.
Find care →Stop allopurinol and seek care immediately for these symptoms
- —Widespread rash, especially blistering or peeling skin, within the first weeks of starting allopurinol
- —Fever, sore throat, or swollen lymph nodes alongside a new rash
- —Yellowing of the skin or eyes (possible liver involvement)
- —Significantly reduced urine output
These symptoms may indicate allopurinol hypersensitivity syndrome. Stop the medication and seek care the same day — go to an emergency department or urgent care.
This article provides general information about allopurinol and gout. Dosing and duration decisions should be made by your clinician, who knows your complete health history and can monitor your response to treatment.
References
- 1.FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. (2020). 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis & Rheumatology. doi:10.1002/art.41247 ✓Allopurinol as preferred first-line ULT; anti-inflammatory prophylaxis during initiation; HLA-B*5801 testing recommendation; indefinite ULT for recurrent gout; uric acid target of 6 mg/dL
- 2.Dalbeth N, Merriman TR, Stamp LK (2016). Gout. Lancet. doi:10.1016/S0140-6736(16)00346-9 ✓Pathophysiology of gout as monosodium urate crystal deposition; role of fructose and dietary factors in uric acid elevation
- 3.National Institute of Arthritis and Musculoskeletal and Skin Diseases (2023). Gout: Symptoms, Causes, and Risk Factors. NIAMS Health Topics. link ✓Gout as a type of inflammatory arthritis caused by urate crystal buildup; risk factors and disease stages including tophi formation
3 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.